Daniel Parker takes us on a tour of Myanmar, Cambodia and Thailand through his work with malaria in areas of conflict. Tired of talking about COVID-19? We are, so as we approach the one-year anniversary of California’s shutdown, we are taking a break. On this special episode of the UCI Podcast, Infectious Disease Specialist Daniel Parker and Communications Officer Nicole Feldman take you on a tour of Myanmar, Cambodia and Thailand. They talk about Parker’s work with diseases that affect millions of people each year but are rarely discussed in the United States.
Public health researcher Andrew Noymer discusses how the novel coronavirus will be with us for a while. Andrew Noymer is an associate professor of public health at UCI, and he’s an expert on public health responses to pandemics like COVID-19 and their long-term consequences. In this special UCI Podcast, he discusses what we’ve learned over the last eight months of the pandemic and what we can expect next with the novel coronavirus. For instance, we need to get prepared for a harsh winter with a surge of infections. Also, he talks about the impact a vaccine can make for having the general population reach herd immunity levels, and our realistic future living with a virus that won’t be going away anytime soon. And don’t forget, wearing a face covering works.
Congratulations to MPH student Herschell Dayag for receiving the UCI Graduate Division’s Brython Davis fellowship in recognition of his outstanding past academic achievements and future promise.
Congratulations to Dr. Oladele Ogunseitan who recently received honors from the Centers for Disease Control and Prevention, Public Health Institute, and Consortium of Universities for Global Health for outstanding service on the 2021 Global Health Workforce Panel.
Other experts will still seek seclusion. Andrew Noymer, an epidemiologist [and associate professor] at University of California, Irvine is plotting some time in his “own little bubble” in the Sierra Nevada mountains.
Andrew Noymer, an associate professor of public health at the University of California, Irvine, recently told Insider that the US may be underestimating the prevalence of asymptomatic infections. Indeed, a recent model suggests that just 13% to 18% of COVID-19 cases are symptomatic. Given that asymptomatic people are less likely to seek a test, this could indicate that official case counts are missing a lot of infections.
Andrew Noymer, a UC Irvine professor of population health and disease prevention, said vaccine distribution has improved in recent weeks. He said he preferred that pharmacies would have taken the lead in getting shots in arms, but added, “ultimately you need both” government-run sites and private health care points of distribution. Overall, the decreases in cases and the ramping up of inoculations has the country heading closer to getting past the pandemic, Noymer said. “The news has never been better in a long time,” Noymer said.